summary: The objective of this study was to review studies of azathioprine, a drug which strongly suppresses the immune system, in treating MS. Although it reduced the relapse rate and progression at three years, there was a risk of potentially serious side effects. Further studies are needed to determine its role in the treatment of MS.

authors: Casetta I, Iuliano G, Filippini G

source: J Neurol Neurosurg Psychiatry. 2009 Feb;80(2):131-132

weblink: click here

category: Clinical Trials and Therapeutics

related research news: click here

glossary: